| Title: | Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosis |
| Journal: | Thorax |
| Published: | 10 Jun 2022 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/35688625/ |
| DOI: | https://doi.org/10.1136/thoraxjnl-2021-218577 |
Publication 18692
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic lung condition with poor survival times. We previously published a genome-wide meta-analysis of IPF risk across three studies with independent replication of associated variants in two additional studies. To maximise power and to generate more accurate effect size estimates, we performed a genome-wide meta-analysis across all five studies included in the previous IPF risk genome-wide association studies. We used the distribution of effect sizes across the five studies to assess the replicability of the results and identified five robust novel genetic association signals implicating mTOR (mammalian target of rapamycin) signalling, telomere maintenance and spindle assembly genes in IPF risk.</p>
5 Keywords
- Genetic Predisposition to Disease
- Genome-Wide Association Study
- Humans
- Idiopathic Pulmonary Fibrosis
- Signal Transduction
12 Authors
- Richard J Allen
- Amy Stockwell
- Justin M Oldham
- Beatriz Guillen-Guio
- David A Schwartz
- Toby M Maher
- Carlos Flores
- Imre Noth
- Brian L Yaspan
- R Gisli Jenkins
- Louise V Wain
- International IPF Genetics Consortium
1 Application
| Application ID | Title |
|---|---|
| 8389 | Genetics of Severe Asthma and Idiopathic Pulmonary Fibrosis |
Enabling scientific discoveries that improve human health